These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 37298200)

  • 1. The Transcription Factor Nrf2 Mediates the Effects of
    Lanza M; Cucinotta L; Casili G; Filippone A; Basilotta R; Capra AP; Campolo M; Paterniti I; Cuzzocrea S; Esposito E
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin E Analog Trolox Attenuates MPTP-Induced Parkinson's Disease in Mice, Mitigating Oxidative Stress, Neuroinflammation, and Motor Impairment.
    Atiq A; Lee HJ; Khan A; Kang MH; Rehman IU; Ahmad R; Tahir M; Ali J; Choe K; Park JS; Kim MO
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-(3,4-Difluorophenyl)-3-(6-methylpyridin-3-yl)-1,2,4-oxadiazole (DDO-7263), a novel Nrf2 activator targeting brain tissue, protects against MPTP-induced subacute Parkinson's disease in mice by inhibiting the NLRP3 inflammasome and protects PC12 cells against oxidative stress.
    Xu LL; Wu YF; Yan F; Li CC; Dai Z; You QD; Jiang ZY; Di B
    Free Radic Biol Med; 2019 Apr; 134():288-303. PubMed ID: 30615919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective potential of plant derived parenchymal stem cells extract on environmental and genetic models of Parkinson disease through attenuation of oxidative stress and neuroinflammation.
    Ishola IO; Oloyo AK; Olubodun-Obadun TG; Godswill OD; Omilabu SA; Adeyemi OO
    Metab Brain Dis; 2023 Feb; 38(2):557-571. PubMed ID: 36401682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Papaverine inhibits α-synuclein aggregation by modulating neuroinflammation and matrix metalloproteinase-3 expression in the subacute MPTP/P mouse model of Parkinson's disease.
    Leem YH; Park JS; Park JE; Kim DY; Kang JL; Kim HS
    Biomed Pharmacother; 2020 Oct; 130():110576. PubMed ID: 32768884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct Nrf2 Signaling Mechanisms of Fumaric Acid Esters and Their Role in Neuroprotection against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Experimental Parkinson's-Like Disease.
    Ahuja M; Ammal Kaidery N; Yang L; Calingasan N; Smirnova N; Gaisin A; Gaisina IN; Gazaryan I; Hushpulian DM; Kaddour-Djebbar I; Bollag WB; Morgan JC; Ratan RR; Starkov AA; Beal MF; Thomas B
    J Neurosci; 2016 Jun; 36(23):6332-51. PubMed ID: 27277809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TMT-based quantitative proteomics analysis of neuroprotective effects of Forsythoside A on the MPTP-induced Parkinson's disease mouse model.
    Niu B; Zhao M; Gao X; Xu J; Yu L
    Exp Neurol; 2024 Mar; 373():114642. PubMed ID: 38056584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective role of SIRT5 against motor deficit and dopaminergic degeneration in MPTP-induced mice model of Parkinson's disease.
    Liu L; Peritore C; Ginsberg J; Shih J; Arun S; Donmez G
    Behav Brain Res; 2015 Mar; 281():215-21. PubMed ID: 25541039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-inflammatory and neuroprotective effects of an orally active apocynin derivative in pre-clinical models of Parkinson's disease.
    Ghosh A; Kanthasamy A; Joseph J; Anantharam V; Srivastava P; Dranka BP; Kalyanaraman B; Kanthasamy AG
    J Neuroinflammation; 2012 Oct; 9():241. PubMed ID: 23092448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SUN11602, a bFGF mimetic, modulated neuroinflammation, apoptosis and calcium-binding proteins in an in vivo model of MPTP-induced nigrostriatal degeneration.
    Ardizzone A; Bova V; Casili G; Filippone A; Campolo M; Lanza M; Esposito E; Paterniti I
    J Neuroinflammation; 2022 May; 19(1):107. PubMed ID: 35526035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multitarget intervention of Fasudil in the neuroprotection of dopaminergic neurons in MPTP-mouse model of Parkinson's disease.
    Zhao YF; Zhang Q; Xi JY; Li YH; Ma CG; Xiao BG
    J Neurol Sci; 2015; 353(1-2):28-37. PubMed ID: 25908255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective role of chloroquine via modulation of autophagy and neuroinflammation in MPTP-induced Parkinson's disease.
    Kartik S; Pal R; Chaudhary MJ; Nath R; Kumar M; Binwal M; Bawankule DU
    Inflammopharmacology; 2023 Apr; 31(2):927-941. PubMed ID: 36715843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of collapsin response mediator protein 4 suppresses dopaminergic neuron death in an 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease.
    Tonouchi A; Nagai J; Togashi K; Goshima Y; Ohshima T
    J Neurochem; 2016 Jun; 137(5):795-805. PubMed ID: 26991935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Açai Berry Mitigates Parkinson's Disease Progression Showing Dopaminergic Neuroprotection via Nrf2-HO1 Pathways.
    D'Amico R; Impellizzeri D; Genovese T; Fusco R; Peritore AF; Crupi R; Interdonato L; Franco G; Marino Y; Arangia A; Gugliandolo E; Cuzzocrea S; Di Paola R; Siracusa R; Cordaro M
    Mol Neurobiol; 2022 Oct; 59(10):6519-6533. PubMed ID: 35970975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.
    Depboylu C; Rösler TW; de Andrade A; Oertel WH; Höglinger GU
    J Neurochem; 2015 May; 133(4):590-7. PubMed ID: 25581060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective effects of Astilbin on MPTP-induced Parkinson's disease mice: Glial reaction, α-synuclein expression and oxidative stress.
    Zhu YL; Sun MF; Jia XB; Cheng K; Xu YD; Zhou ZL; Zhang PH; Qiao CM; Cui C; Chen X; Yang XS; Shen YQ
    Int Immunopharmacol; 2019 Jan; 66():19-27. PubMed ID: 30419450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective effects of tetramethylpyrazine against dopaminergic neuron injury in a rat model of Parkinson's disease induced by MPTP.
    Lu C; Zhang J; Shi X; Miao S; Bi L; Zhang S; Yang Q; Zhou X; Zhang M; Xie Y; Miao Q; Wang S
    Int J Biol Sci; 2014; 10(4):350-7. PubMed ID: 24719552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyruvate Prevents Dopaminergic Neurodegeneration and Motor Deficits in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Model of Parkinson's Disease.
    Kim YM; Choi SY; Hwang O; Lee JY
    Mol Neurobiol; 2022 Nov; 59(11):6956-6970. PubMed ID: 36057709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bruceine D elevates Nrf2 activation to restrain Parkinson's disease in mice through suppressing oxidative stress and inflammatory response.
    Yang Y; Kong F; Ding Q; Cai Y; Hao Y; Tang B
    Biochem Biophys Res Commun; 2020 Jun; 526(4):1013-1020. PubMed ID: 32321640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Neuroprotective Effect of Dimethyl Fumarate in an MPTP-Mouse Model of Parkinson's Disease: Involvement of Reactive Oxygen Species/Nuclear Factor-κB/Nuclear Transcription Factor Related to NF-E2.
    Campolo M; Casili G; Biundo F; Crupi R; Cordaro M; Cuzzocrea S; Esposito E
    Antioxid Redox Signal; 2017 Sep; 27(8):453-471. PubMed ID: 28006954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.